Search
news › trial-results-show-potential-benefits-of-tocilizumab-for-covid-19
… clinical trials around the world as a potential treatment for COVID-19. A team of international researchers present … patients will benefit the most from this treatment. In the coming weeks, results are expected from the REMDACTA trial, which is studying the effects of tocilizumab in combination with remdesivir, an FDA approved anti-viral …
news › baylor-awarded-17-5-million-in-cprit-grants-for-cancer-research
… and leader of the Breast Cancer Program at the Dan L Duncan Comprehensive Cancer Center : Baylor College of Medicine Comprehensive Cancer Training Program - $3,974,082 Dr. … epidemiology and population sciences: Systems Epidemiology for Cancer Training Program (SECT Program) - $3,593,867 …
news › novel-gene-therapy-for-heart-failure-closer-to-the-clinic
… that knocking down the Hippo signaling pathway in cardiomyocytes in the hearts of pigs after they had a heart … need for alternative treatments. “One of the interests of my lab is to develop ways to heal heart muscle by studying … lab revealed that turning the Hippo signaling pathway off in a mouse model that mimics advanced human heart …
healthcare › clinical-trials › h-45617
… Insomnia is common in hospitalized older adults and carries a … attention, motivation, along with increased fatigue and compensatory behaviors (e.g., napping). These daytime … We are seeking patients (ages 55+) scheduled for hip or knee arthroplasty to take part in our 6-month …
news › drug-for-high-triglycerides-has-sustained-effect-at-low-dosages
… a treatment at low dosages that can be given infrequently for those with hard-to-treat, high-triglyceride levels who … 1,000 mg/dL are considered severe. Those numbers are not common but are difficult to control and can contribute to an … of pancreatitis, a painful and life-threatening disorder. For this study, researchers used a single dose in healthy …
news › dr-jihye-yun-named-pew-stewart-scholar-for-cancer-research
… molecular and human genetics and member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, … named to the 2020 class of the Pew-Stewart Scholars Program for Cancer Research. Yun’s work will focus on decoding the … supports cancer researchers working toward a cure for the complex disease. The five early career scholars who make up …
news › new-guidance-finds-best-treatment-for-breast-cancer-during-pandemic
… endocrine-sensitive tumors and who should be prioritized for early surgery or neoadjuvant chemotherapy, or an endocrine-sensitive tumor that can be treated for up to 6 months with an endocrine drug with a safe … breast and HER2-positive cancer have still been going forward for urgent surgery or chemotherapy, it is safe for a …
news › exome-sequencing-for-infants-in-icu
… the majority of known defects occur. The research team performed clinical exome sequencing for 278 unrelated infants who were 100 days old or younger. … from critical exome sequencing take about two weeks to complete, which is much faster than many other diagnostic …
news › forum-on-arts-health-promotion-to-be-held
… County academic institutions, public health systems and community service organizations, including the … at Baylor College of Medicine, will host an educational forum March 24 on how to use various art forms to promote … a.m. to 12:30 p.m. at the United Way of Greater Houston Community Resource Center, 50 Waugh Dr., 77007. Free parking …
news › gene-sequencing-screening-for-hearing-loss
… took part in this work include Donna Muzny, Dr. Yi Han, Dr. Min Wang and Fiona Ongeri of the BCM Human Genome Sequencing …